Pentadecapeptide studied for cytoprotective signaling, VEGF/EGF modulation, and extracellular matrix interactions.
Thymosin β4 C-terminal fragment (Ac-SDKP) for actin-binding dynamics and endothelial cell migration assays.
Co-lyophilized BPC-157 (15mg) and TB-500 Fragment (15mg) in a single vial for concurrent pathway research.
Long-acting GLP-1 receptor agonist analog for pancreatic β-cell signaling and incretin axis research.
Dual GIP/GLP-1 receptor co-agonist for comparative receptor selectivity and metabolic pathway research.
High-concentration format of the dual GIP/GLP-1 co-agonist for extended assay series.
Triple GLP-1/GIP/GCG receptor agonist for incretin crosstalk and glucagon pathway research.
High-concentration triple GLP-1/GIP/GCG agonist for extended research series and multi-dose protocols.
Mitochondria-derived peptide for AMPK pathway activation and mitochondrial biogenesis signaling research.
Copper(II) tripeptide complex for MMP modulation, collagen synthesis, and NF-κB inflammatory pathway studies.
Selective GHSR-1a agonist with minimal off-target receptor activity for pituitary cell signaling studies.
Growth hormone-releasing hexapeptide and standard reference compound for GHSR-1a binding studies.
Broad-spectrum melanocortin receptor agonist (MC1R–MC5R) for pigmentation and cAMP pathway research.
Bremelanotide with preferential MC3R/MC4R affinity for CNS melanocortin and hypothalamic signaling studies.